Retatrutide

$108.00

Retatrutide

$108.00

MEDANNI Retatrutide

Retatrutide is an investigational triple-receptor agonist reference compound studied in controlled metabolic research. MEDANNI presents it as an investigational catalog item and does not imply approval for therapeutic use.

Product information

  • Brand: MEDANNI
  • Format: Research material
  • Available strength: Replace with verified specification
  • Purity: Replace with batch COA result
  • Documentation: Add identity and purity reports
  • Storage and shipping: Replace with verified requirements

IMAGE TO REPLACE: Add your MEDANNI vial and packaging photographs.

Investigational research reference only. Not approved for self-medication or human consumption. Confirm legal eligibility and platform rules before sale.

You may also like